Back to Vontobel Holding Ltd. Vontobel Holding Ltd.

BBIOBBIO

Showing 6 of 13 quarters

Position history for Vontobel Holding Ltd.Vontobel Holding Ltd.'s holdings in BridgeBio Pharma, Inc.

Yes. Vontobel Holding holds 35,124 shares of BBIO (BridgeBio Pharma), worth $2.3M, as of its Q3 2026 13F filing. It reduced the position by 239 shares (-0.7%) from Q2 2026. Vontobel Holding has held BBIO since Q2 2025, across 6 quarterly 13F filings.

Current Value

$2.3M

Current Shares

35,124

Total Value Change

+$1.9M

Total Shares Change

+25,294

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
35,124
-0.7%
$2.3M0.0%$65.80
0
2026-Q2
Increased
35,363
+97.9%
$2.6M0.0%$74.48
42
2026-Q1
Decreased
17,872
-6.2%
$1.3M0.0%$74.26
0
2025-Q4
Increased
19,062
+82.5%
$1.5M0.0%$76.49
39
2025-Q3
Increased
10,442
+6.2%
$542,3570.0%$51.94
26
2025-Q2
New
9,830
—
$424,4590.0%$43.18
33

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used